Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

National Pet Poison Helpline Affirms Safety of Seresto Flea and Tick Collar Use

(PRNewsfoto/Pet Poison Helpline)

News provided by

Pet Poison Helpline

May 26, 2021, 10:15 ET

Share this article

Share toX

Share this article

Share toX

MINNEAPOLIS, May 26, 2021 /PRNewswire/ --

Summary
Pet Poison Helpline, a recognized national leader in animal toxicology and pet health, has thoroughly reviewed both the scientific literature on Seresto flea and tick collars and our own animal poison control case data. As with any medication for you or your pet, it is important to compare the potential risks of a treatment with the proven benefits. In the medical opinion of our boarded veterinary toxicology experts these collars are a safe and important treatment for the vast majority of cats and dogs. The health protections these collars provide far outweigh the extremely rare risk of a serious adverse event. People who avoid using these products out of concern for a negative reaction may be putting their pets at greater risk of harm by leaving them susceptible to diseases caused by fleas and ticks such as Lyme disease, Ehrlichiosis, Anaplasmosis and Rocky Mountain Spotted Fever. These diseases pose a far greater health risk to a pet than Seresto collars. To help veterinary professionals and pet owners better understand the risks and benefits of Seresto, we have summarized our findings below.

Continue Reading

Detailed Response
Several news agencies have recently reported concerns over the safety of Seresto collars. As an organization dedicated to pet health and safety and one of North America's leading authorities in veterinary toxicology, Pet Poison Helpline has extensive experience analyzing the safety of animal health products, including flea and tick preventatives. We are uniquely familiar with the safety profiles of such products both when used per labeled instructions and in situations involving accidental ingestion or unintended contact. Further, we have both created and examined safety data published about flea and tick products, including Seresto. To help veterinary professionals and pet owners understand the risks and benefits of Seresto, we would like to share our experiences with this product.

"These diseases pose a far greater health risk to a pet than Seresto collars."

Post this

Pet Poison Helpline Case Data
Since 2013, Pet Poison Helpline has managed approximately 400 cases involving Seresto, the majority of which involved dogs ingesting all or a portion of the collar. Ingesting the product is far more dangerous to a pet than simply wearing one because the pesticides are not usually absorbed across the skin, but they can be directly absorbed from the gastrointestinal tract. Therefore, any case of collar ingestion is potentially concerning. Of our more than 400 cases, more than a third of exposed dogs/cats remained asymptomatic and, for those that did develop clinical signs, the majority were mild and self-limiting. Vomiting was the most common sign, experienced by approximately 50 percent of patients. This is unsurprising as vomiting may be caused by both pyrethroids (one of Seresto's active ingredients) and ingestion of foreign material (i.e., collar). Other signs included diarrhea and a decreased appetite in nearly 6 percent of patients. Lethargy was reported in approximately 13 percent of patients and often occurs concurrently with vomiting, diarrhea and anorexia. Ataxia was observed in about 3 percent of cases with panting and agitation noted in 1-2 percent. All other reported signs occurred in less than 1 percent of animals. The most notable finding in our data is the distinct lack of severe neurological signs such as tremors, severe ataxia, and seizures—signs that are consistent with pyrethroid poisoning. Despite entire collars being chewed and swallowed, there were no reports of death. 

As the nation's leading animal toxicology experts, we consider ourselves the eyes and ears of the nation when it comes to pet safety. Typically, when products cause severe injury to pets, our center would quickly become aware as veterinary professionals would be calling us for treatment advice. The fact that nearly 40 percent of pets that ingested the collars remained asymptomatic, and when clinical signs occurred most were minor and self-limiting, provides strong evidence to support the safety profile of Seresto.

Explanation of Data Reported to EPA
Many of the news stories about the potential safety concerns with Seresto are based on one article issued by a non-medical news organization that tallied raw numbers of adverse event data previously submitted to the EPA by Seresto's manufacturer. It is important to understand that any time a pet owner or veterinary professional contacts a company to report an adverse effect involving an EPA (or FDA) regulated product, the company is legally required to report the allegation to regulators, regardless of whether that adverse event has been substantiated by a medical professional or was truly caused by the product. The good news is that this makes for an extremely sensitive post-market surveillance system. The challenge with such systems is that there are a lot of reported incidents that ultimately have nothing to do with the product. For example, if a pet owner placed a flea and tick collar on their dog and two days later, he stopped eating, started vomiting, and was straining to defecate, the pet owner might call the manufacturer to ask if the collar could be the cause of their dog's signs since this was the only change in their pet's environment. Although these signs would not be expected from wearing a flea/tick collar, the manufacturer must still document this information as an adverse event and report it to EPA. If a veterinarian later determined that the collar was not the cause of the dog's signs and instead diagnosed him with a bowel obstruction caused by eating part of a tennis ball, the collar manufacturer must still report the dog's illness to the EPA as an adverse event, even though the reaction had nothing to do with the collar.

Contextualizing Raw Adverse Event Data
Raw case counts can be challenging to interpret and when the absolute numbers are large, it is understandable that pet owners and their veterinarians can become concerned. To be placed in context, however, the raw numbers must be compared to the number of products sold. In the case of Seresto, more than 25 million collars have been sold in the US. When comparing this number to the total number of reported adverse events, it is evident that the incidence rate of reported adverse events is quite small (0.3 percent or 3 out of 1,000)1.

Next, it is important to examine the severity of the adverse events. If most involve minor problems such as hair breakage or skin irritation at the collar site, this may be in line with expected side effects from wearing a close-fitted collar. While those side effects may mean that the specific collar is not the best option for that particular pet, it does not mean that the product, in general, is unsafe or should not be used on other pets. In the case of Seresto, 90 percent of adverse events involved minor effects.1

It is also imperative to look closely at any case involving death or serious illness that occurred in a pet to better determine if the product contributed to those outcomes. The board-certified toxicology experts at Pet Poison Helpline are often contracted to perform independent safety reviews of consumer and animal health products. In 2016 we were asked by then Bayer Animal Health to perform an expert review of pet fatality reports associated with Seresto. After a thorough review of the scientific literature and research involving flumethrin and imidacloprid, the active ingredients in Seresto, along with a careful review of each individual case, we concluded that the vast majority of fatalities were highly unlikely to be caused by the use of Seresto. In fact, many had other well-documented and unrelated causes of death. For the few cases where a relationship between Seresto and the pet's death could not be ruled out, one cannot exclude the possibility of a rare idiosyncratic reaction.

Conclusion
We strongly agree that pet owners should be aware of potential side effects Seresto collars or any other types of products can cause in both animals and humans, but we think the recent media reports have misrepresented the true risk of harm and discounted or disregarded the benefits and valuable protections these collars provide to tens of millions of pets and their owners who can be infected. In its totality, we think the science continues to support the safe and effective use of Seresto collars to prevent flea and tick-borne illness in pets and their human families.

About Pet Poison Helpline
Pet Poison Helpline, an animal poison control center based in Minneapolis, is available 24 hours, seven days a week for pet owners and veterinary professionals who require assistance treating a potentially poisoned pet. The veterinarians and board-certified toxicologists provide treatment advice for poisoning cases of all species, including dogs, cats, birds, small mammals, large animals and exotic species. As the most cost-effective option for animal poison control care, Pet Poison Helpline's fee of $65 per incident includes follow-up consultations for the duration of the poison case. Pet Poison Helpline is available in North America by calling 800-213-6680. Additional information can be found online at www.petpoisonhelpline.com.

1 Cima G. Seresto collars come under greater scrutiny: Elanco defends product, experts remain comfortable with their use. Journal of the American Veterinary Medical Association. May 1, 2021, Vol. 258, No. 9, Pages 916-918.

Contact: Maja Ferrell 
Pet Poison Helpline
(952) 852-4608
[email protected]  

SOURCE Pet Poison Helpline

Related Links

http://www.petpoisonhelpline.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Snooping Pooch Sneaks a Snack of Eczema Cream

Snooping Pooch Sneaks a Snack of Eczema Cream

Pets often have a favorite spot in the house. Whenever the Clark family is looking for their dog Ruby, they know exactly where to check. "I thought...

Police Dogs Leap into Toxic Training Situation

Police Dogs Leap into Toxic Training Situation

Law enforcement officers and their canine partners are often seen leaping into dangerous situations to save others, but what happens when these...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Animals & Pets

Animals & Pets

Animal Welfare

Animal Welfare

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.